1. Will CETP inhibition survive the demise of torcetrapib?

   • Anders G. Olsson

   Invited Commentary 06 April 2008 Pages: 97 - 99

2. Web alert

   OriginalPaper 06 April 2008 Pages: 100 - 100

3. Clinical trials report

   • John A. Farmer

   Report 06 April 2008 Pages: 103 - 105

4. Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes

   • Martial G. Bourassa
   • Colin Berry

   OriginalPaper 06 April 2008 Pages: 106 - 116

5. Alcohol consumption and heart failure: A systematic review

   • Luc Djoussé
   • J. Michael Gaziano

   OriginalPaper 06 April 2008 Pages: 117 - 120

6. Racial and ethnic differences in hypertension

   • Deborah S. Minor
   • Marion R. Wofford
   • Daniel W. Jones

   OriginalPaper 06 April 2008 Pages: 121 - 127

7. Rheumatoid arthritis and cardiovascular disease

   • Saurabh S. Dhawan
   • Arshed A. Quyyumi

   OriginalPaper 06 April 2008 Pages: 128 - 133

8. PPARγ agonists and coronary atherosclerosis

   • Melanie S. Sulistio
   • Adrienne Zion
   • Robert Chilton

   OriginalPaper 06 April 2008 Pages: 134 - 141

9. Adjunctive interventions in myocardial infarction: The role of statin therapy

   • Peter H. Jones
   • John A. Farmer

   OriginalPaper 06 April 2008 Pages: 142 - 148

10. Aspirin resistance in atherosclerosis

    • Price Blair
    • Jane E. Freedman

    OriginalPaper 06 April 2008 Pages: 149 - 157

11. Intensive statin therapy in acute coronary syndromes

    • Tze Vun Liew
    • Kausik K. Ray

    OriginalPaper 06 April 2008 Pages: 158 - 163

12. Novel markers of inflammation in atherosclerosis

    • Salim S. Virani
    • Venkateshwar R. Polsani
    • Vijay Nambi

    OriginalPaper 06 April 2008 Pages: 164 - 170

13. Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides

    • Roger Yu
    • Babak Yekta
    • Abbas Ardehali

    OriginalPaper 06 April 2008 Pages: 171 - 176